期刊文献+

侧颅底肿瘤的诊断和治疗进展 被引量:4

原文传递
导出
出处 《中华全科医学》 2010年第4期492-493,共2页 Chinese Journal of General Practice
  • 相关文献

参考文献20

  • 1Kaylie DM, Wittkopf JE, Coppit G. Revision lateral skullbase sur-gery [ J ]. Otol Neurotol,2006,27 (2) :225-233.
  • 2胡晓光,雷德林,林成,吴炜,马秦,程晓兵,张圃,孙沫逸,杨耀武.不同区域颅底肿瘤的组织来源特点及手术方案的选择[J].现代肿瘤医学,2008,16(6):935-937. 被引量:2
  • 3Pisaneschl M J, Langer B. Congenital cholesteatoma and choleatertol granuloma of the temporal bone:role ofmagnetic resonance imaging [ J ]. Top Magn Reson Imaging,2000,11 ( 2 ) :87-97.
  • 4杨卫东,孙健,曾峥,浦佩玉,张建宁,李富华,高硕,蔡丽,李威,毓青.立体定向影像融合技术引导的脑胶质瘤活检和手术治疗[J].中华外科杂志,2005,43(21):1421-1422. 被引量:6
  • 5Kaylie DM, Wittkopf JE, Coppit G, et al. Revision lateral skullbase surgery [ J ]. Otol Neurotol,2006,27 ( 2 ) :225-233.
  • 6Cunningham CD 3rd, Friedman RA, Brackmann DE,et al. Neurotologic skull base surgery in pediatric patients[J]. Otol Neurotol,2005,26 (2) :231-236.
  • 7Kawahara N, Sasaki T, Asakage T, et al. Long-term out-come following radical temporal bone resection for lateral skull base malignancies: a neurosurgical perspective [ J ]. J Neurosurg,2008,108 (3) :501-510.
  • 8Sanna M, Jain Y, DeDonato G, et al. Managementof jugularpara-gangliomas: the Gruppo Otologico experience [ J ]. Otol Neurotol, 2004,25 ( 5 ) :797-804.
  • 9Tasar M, Yetiser S. Glomus tumors : therapeutic role of selec-tive embolization [ J ]. J Craniofacial Surg ,2004,15 ( 3 ) :497-505.
  • 10陈伟正,杨熙鸿,林建英,郭海鹏.颈淋巴结清扫术对肩功能的影响[J].中国临床康复,2005,9(26):133-133. 被引量:5

二级参考文献93

  • 1翁鸢,常建华,常庆,蔡铭.新辅助化疗加手术治疗Ⅲ期食管贲门癌的疗效观察[J].山东医药,2005,45(6):42-43. 被引量:7
  • 2王发恒,焦峰,李向阳,赵一奇,周大勇,丁友宏.全胃切除治疗贲门癌280例[J].临床肿瘤学杂志,2005,10(5):528-529. 被引量:2
  • 3吴明拜,张铸,张力为,伊力亚尔夏合丁,张昌明,朱辉,李德生,库尔班.食管癌和贲门癌外科治疗的2019例临床分析[J].中华肿瘤防治杂志,2006,13(5):378-379. 被引量:10
  • 4[1]Kang X Q,et al.Identification of a tyrosinase epitope recognized by HLA-A24-restricted,tumor-infiltrating lymphocytes.J Immunol, 1995,155(3):1343
  • 5[2]Kawakami Y,et al.Recognition of multiple epitopes in the human melanoma antigen gp100by tumor-infiltrating T lymphocytes associ-atedwith in vivo tumor regression.J Immunol,1995,154(8):3961
  • 6[3]Wolfel T,et al.Isolation of naturally processed peptides recognized by cytolytic T lymphocytes(CTL)on human melanoma cells in asso-ciation with HLA-A2.1.Int J Cancer,1994,57(3):413
  • 7[4]Yamshchikov G V,et al.Evaluation of peptide vaccine immuno-genicity in draining lymph nodes and peripheral blood of melanoma patients.Int J Cancer,2001,92(5):703
  • 8[5]Jager E,et al.CTL-defined cancer vaccines:Perspectives for active immunotherapeutic interventions in minimal residual disease.Cancer and Metast Rev,1999,18(1):143
  • 9[6]Printz C.Spontaneous regression of melanoma may offer insight into cancer immunology.J Natl Cancer Inst,2001,93(14):1047
  • 10[7]Lacquaniti S,et al.Spontaneous partial fibrotic regression of a pri-maryrenal carcinoma:A case report.Arch Ital Urol Androl,1999,71(1):35

共引文献20

同被引文献20

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部